Back
Bicara Therapeutics Vs. BRP Industry Stock Comparison
Buy
62
BCAX
Bicara Therapeutics
Last Price:
$13.41
Seasonality Move:
--
Sell
20
DOOO
BRP
Last Price:
$33.97
Seasonality Move:
28.36%
Buy
62
Bicara Therapeutics (BCAX)
is a Buy
Is Bicara Therapeutics a Buy, Sell or Hold?
-
The current Bicara Therapeutics [BCAX] share price is $13.40. The Score for BCAX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
BCAX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $13.40The current trend is relatively stagnant and BCAX is experiencing slight selling pressure.
DOOO Stock Price Chart
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 49.87 | Sell |
Chaikin Money Flow: | -141254 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.39 - 14.45) | Sell |
Bollinger Bands (100): | (12.32 - 20.16) | Sell |
DOOO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.79 | Buy |
Relative Strength Index (14 RSI): | 34.19 | Sell |
Chaikin Money Flow: | -33953 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.84 - 40.52) | Sell |
Bollinger Bands (100): | (41.23 - 52.15) | Sell |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.18 | Buy |
20-day SMA: | 13.57 | Sell |
50-day SMA: | 12.96 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 13.28 | Buy |
20-day EMA: | 13.33 | Buy |
50-day EMA: | 13.76 | Sell |
200-day EMA: | 11.32 | Buy |
DOOO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.74 | Sell |
20-day SMA: | 38.18 | Sell |
50-day SMA: | 43.23 | Sell |
200-day SMA: | 55.19 | Sell |
8-day EMA: | 29.79 | Buy |
20-day EMA: | 18.27 | Buy |
50-day EMA: | 8.89 | Buy |
200-day EMA: | 2.46 | Buy |
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and a decrease next year of $0.51 per share.
BRP Earnings Growth & DOOO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.29 per share, a decrease this year of $5.12 per share, and a decrease next year of $0.51 per share.
Bicara Therapeutics Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BRP Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |